Status:
ACTIVE_NOT_RECRUITING
Fentanyl Versus Midazolam as an Adjunct to Spinal Anesthesia
Lead Sponsor:
Makassed General Hospital
Conditions:
Healthy Female Volunteer
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
It is well documented in the practice of anesthesia the effectiveness of bupivacaine when added with other adjuvants including midazolam, opioids, and ketamine during neuraxial spinal block for cesare...
Detailed Description
A study published on Jan - Feb 2024 has compared adjuvants fentanyl 25 micrograms and midazolam 2mg when added to Levobupivacaine for patients undergoing cesarean section with Midazolam being the supe...
Eligibility Criteria
Inclusion
- Patients aged 18-45 with American Society of Anesthesia (ASA) class II will be included in the study.
Exclusion
- patients with history of opioid substance abuse
- pre-eclampsia or eclampsia
- Gestational Hypertension
- uncontrolled diabetes mellitus
- significant cardiac, renal, and hepatic morbidity (i.e., ASA class III patients).
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06917898
Start Date
April 1 2025
End Date
April 30 2026
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Makassed General Hospital
Beirut, Lebanon, Lebanon, 00000